Form 4: Supernus Pharmaceuticals Executive Padmanabh P. Bhatt Reports Stock Transactions
SEC Form 4 Filing
Padmanabh P. Bhatt, a Senior VP at Supernus Pharmaceuticals, reported the acquisition and disposal of company stock on February 23, 2024, according to a Form 4 filing.
Summary
- On February 23, 2024, Padmanabh P. Bhatt, a Senior VP at Supernus Pharmaceuticals, engaged in stock transactions.
- Bhatt acquired 1,250 shares of common stock at $0 and disposed of 638 shares at $29.06 to cover tax withholding requirements related to RSU vesting.
- Following these transactions, Bhatt directly owns 8,570 shares of Supernus common stock.
- Bhatt also holds 3,750 Restricted Stock Units (RSUs), each representing the right to receive one share of Supernus common stock upon vesting in four equal annual installments starting February 23, 2024.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track executive compensation and potential alignment with shareholder interests.
Key Dates
| Date | Description |
|---|---|
| 02/23/2024 | Date of stock transactions and first vesting date of Restricted Stock Units. |
| 02/27/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.